Scinai Immunotherapeutics (SCNI) Cash From Investing

Annual CFI

-$637.00 K
+$199.00 K+23.80%

31 December 2023

1-Year Change

+23.8%
SCNI annual cash flow from investing activities is up +23.8% year-on-year

3-Year Change

+65.49%
SCNI annual cash flow from investing activities is up +65.49% over the past 3 years

All-time High

$1.94 M
SCNI annual cash flow from investing activities is currently -132.76% below its historical high of $1.94 million

Sector Rank

47.51%
SCNI annual cash flow from investing activities is higher than 47.51% of companies in Healthcare sector
Annual CFF$1.09 M
SCNI annual cash flow from financing activities is $1.09 million
Annual CFO-$9.38 M
SCNI annual cash flow from operations is -$9.38 million
Annual FCF-$10.02 M
SCNI annual free cash flow is -$10.02 million

SCNI Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

-$6000.00
-$4000.00-200.00%

30 June 2024

1-Year Change

+70%
SCNI quarterly cash flow from investing activities is up +70% year-on-year

All-time High

$1.58 M
SCNI quarterly cash flow from investing activities is currently -100.38% below its historical high of $1.58 million

Sector Rank

53.43%
SCNI quarterly cash flow from investing activities is higher than 53.43% of companies in Healthcare sector
Quarterly CFF$12.00 K
SCNI quarterly cash flow from financing activities is $12.00 thousand
Quarterly CFO-$1.76 M
SCNI quarterly cash flow from operations is -$1.76 million
Quarterly FCF-$1.76 M
SCNI quarterly free cash flow is -$1.76 million
Quarterly CAPEX$6000.00
SCNI quarterly capital expenditures is $6000.00

SCNI Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

-$262.00 K
+$371.00 K+58.61%

30 June 2024

1-Year Change

+61.07%
SCNI TTM cash flow from investing activities is up +61.07% year-on-year

All-time High

$3.68 M
SCNI TTM cash flow from investing activities is currently -107.12% below its historical high of $3.68 million

Sector Rank

52.04%
SCNI TTM cash flow from investing activities is higher than 52.04% of companies in Healthcare sector
TTM CFF$2.52 M
SCNI TTM cash flow from financing activities is $2.52 million
TTM CFO-$6.67 M
SCNI TTM cash flow from operations is -$6.67 million
TTM FCF-$6.93 M
SCNI TTM free cash flow is -$6.93 million
TTM CAPEX$6000.00
SCNI TTM capital expenditures is $6000.00

SCNI TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SCNI Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.8%+70.0%+61.1%
3 y3 years+65.5%--
5 y5 years+89.8%--

SCNI Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-358.3%+65.5%-117.1%+98.8%at high+68.7%
5 y5 years-358.3%+89.8%-117.1%+98.8%at high+68.7%
alltimeall time-132.8%+89.8%-100.4%+99.8%-107.1%+95.9%

Scinai Immunotherapeutics Cash From Investing History

DateAnnualQuarterlyTTM
June 2024
-
-$6000.00(+200.0%)
-$262.00 K(-58.6%)
Mar 2024
-
-$2000.00(-99.1%)
-$633.00 K(-0.6%)
Dec 2023
-$637.00 K(-23.8%)
-$234.00 K(+1070.0%)
-$637.00 K(-5.3%)
Sept 2023
-
-$20.00 K(-94.7%)
-$673.00 K(-8.2%)
June 2023
-
-$377.00 K(+6183.3%)
-$733.00 K(+128.3%)
Mar 2023
-
-$6000.00(-97.8%)
-$321.00 K(-61.6%)
Dec 2022
-$836.00 K(+501.4%)
-$270.00 K(+237.5%)
-$836.00 K(+47.7%)
Sept 2022
-
-$80.00 K(-328.6%)
-$566.00 K(+16.5%)
June 2022
-
$35.00 K(-106.7%)
-$486.00 K(-6.7%)
Mar 2022
-
-$521.00 K(+100.2%)
-$521.00 K(-85.6%)
Dec 2021
-$139.00 K(-92.5%)
-
-
Dec 2020
-$1.85 M(-11.2%)
-
-
Dec 2019
-$2.08 M(-66.6%)
-
-
June 2019
-
-$260.30 K(-70.2%)
-$3.62 M(-28.5%)
Mar 2019
-
-$872.10 K(+8.4%)
-$5.06 M(-18.8%)
Dec 2018
-$6.23 M(-420.2%)
-$804.50 K(-52.1%)
-$6.23 M(-2.2%)
Sept 2018
-
-$1.68 M(-1.3%)
-$6.36 M(+76.1%)
June 2018
-
-$1.70 M(-16.7%)
-$3.61 M(+986.7%)
Mar 2018
-
-$2.04 M(+117.0%)
-$332.60 K(-117.1%)
DateAnnualQuarterlyTTM
Dec 2017
$1.94 M(-195.7%)
-$941.40 K(-187.9%)
$1.94 M(-47.2%)
Sept 2017
-
$1.07 M(-32.2%)
$3.68 M(+30.4%)
June 2017
-
$1.58 M(+575.6%)
$2.82 M(-257.5%)
Mar 2017
-
$234.00 K(-70.5%)
-$1.79 M(-11.8%)
Dec 2016
-$2.03 M(>+9900.0%)
$794.30 K(+272.0%)
-$2.03 M(-26.0%)
Sept 2016
-
$213.50 K(-107.0%)
-$2.75 M(-9.7%)
June 2016
-
-$3.03 M(>+9900.0%)
-$3.04 M(>+9900.0%)
Mar 2016
-
-$4800.00(-106.1%)
-$15.80 K(+43.6%)
Dec 2015
-$11.00 K(-76.2%)
$79.10 K(-198.9%)
-$11.00 K(-87.5%)
Sept 2015
-
-$80.00 K(+692.1%)
-$87.80 K(+1525.9%)
June 2015
-
-$10.10 K(<-9900.0%)
-$5400.00(-258.8%)
Mar 2015
-
$0.00(-100.0%)
$3400.00(-107.3%)
Dec 2014
-$46.20 K(-107.9%)
$2300.00(-4.2%)
-$46.30 K(-4.7%)
Sept 2014
-
$2400.00(-284.6%)
-$48.60 K(-4.7%)
June 2014
-
-$1300.00(-97.4%)
-$51.00 K(+2.6%)
Mar 2014
-
-$49.70 K
-$49.70 K
Dec 2013
$581.20 K(-618.0%)
-
-
Dec 2012
-$112.20 K(-84.6%)
-
-
Dec 2011
-$730.20 K
-
-

FAQ

  • What is Scinai Immunotherapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics annual CFI year-on-year change?
  • What is Scinai Immunotherapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics quarterly CFI year-on-year change?
  • What is Scinai Immunotherapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Scinai Immunotherapeutics?
  • What is Scinai Immunotherapeutics TTM CFI year-on-year change?

What is Scinai Immunotherapeutics annual cash flow from investing activities?

The current annual CFI of SCNI is -$637.00 K

What is the all time high annual CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high annual cash flow from investing activities is $1.94 M

What is Scinai Immunotherapeutics annual CFI year-on-year change?

Over the past year, SCNI annual cash flow from investing activities has changed by +$199.00 K (+23.80%)

What is Scinai Immunotherapeutics quarterly cash flow from investing activities?

The current quarterly CFI of SCNI is -$6000.00

What is the all time high quarterly CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high quarterly cash flow from investing activities is $1.58 M

What is Scinai Immunotherapeutics quarterly CFI year-on-year change?

Over the past year, SCNI quarterly cash flow from investing activities has changed by +$14.00 K (+70.00%)

What is Scinai Immunotherapeutics TTM cash flow from investing activities?

The current TTM CFI of SCNI is -$262.00 K

What is the all time high TTM CFI for Scinai Immunotherapeutics?

Scinai Immunotherapeutics all-time high TTM cash flow from investing activities is $3.68 M

What is Scinai Immunotherapeutics TTM CFI year-on-year change?

Over the past year, SCNI TTM cash flow from investing activities has changed by +$411.00 K (+61.07%)